UCB

UCB

Belgium Belgium

UCB is a Belgian biopharmaceutical company headquartered in Brussels and founded in 1928, listed on Euronext Brussels. The company focuses on neurology, including the epilepsy drugs Vimpat and Briviact and the multiple-sclerosis treatment Bimzelx, and on immunology with Cimzia.

Its epilepsy portfolio in particular is globally relevant.

Featured on: Did you know that some of the world’s most important medicines come from Europe?
Did you know that some of the world’s most important medicines come from Europe?
From Aspirin to mRNA vaccines: the European pharma companies still leading medical science.
Visit website

Featured on Euronomy?

Promote, advertise or partner with us

Leave your details and we will get back to you.

Add the Featured on Euronomy badge

Paste this snippet where you want the badge to appear. It links back to Euronomy.